Nephrotoxicity of vancomycin and teicoplanin alone and in combination with an aminoglycoside

Taiwan Pharmaceutical Journal

Volumn 59, Issue 1, 2007, Pages 1-8

  Huang, Li Ying ^a   Wang, Chun Yu ^a   Jang, Tsrang Neng ^a   Yeh, Hseng Long ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Aminoglycoside; Nephrotoxicity; Teicoplanin; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPERTENSION; INTENSIVE CARE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEPHROTOXICITY;

EID: 38549106004     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Finch, R. G.; Eliopoulos, G. M. Safety and efficacy of glycopeptide antibiotics. J. Antimicrob. Chemother. 2005, 55, S2: ii5-ii13.
2. Nishino, Y.; Takemura, S.; Minamiyama, Y. et al. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox. Rep. 2002, 7, 317-319.
3. Wood, M. J. The comparative efficacy and safety of teicoplanin and vancomycin. J. Antimicrob. Chemother. 1996, 37, 209-222.
4. Farber, B. F.; Moellering, R. C. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 1983, 23, 138-141.
5. Goetz, M. B.; Sayers, J. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J. Antimicrob. Chemother. 1993, 32, 325-334.
6. Rybak, M. J.; Albrecht, L. M.; Boike, S. C. et al. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J. Antimicrob. Chemother. 1990, 32, 679-687.
7. Fitzsimmons, W. E.; Postelnick, M. J.; Tortorice, P. V. Survey of vancomycin monitoring guidelines in Illinois hospitals. Drug. Intell. Clin. Pharm. 1988, 22, 598-600.
8. Appel, G. B.; Given, D. B.; Levin, L. R. et al. Vancomycin and the kidney. Am. J. Kid. Dis. 1986, 8, 75-80.
9. Downs, N. J.; Neihart, R. E.; Dolezal, J. M.; Hodges, G. R. Mild nephrotoxicity associated with vancomycin use. Arch. Intern. Med. 1989, 149, 1777-1781.
10. Michael, J. R.; Betty, J. A.; Stephen, A. L.; George, L. D. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999, 43, 1549-1555.
11. Bhatt, M. V.; Schumacher, R. E.; Faix, R. G.; Leady, M. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Pediatrics. 1999, 103, e48.
12. Chandrasekar, P. H.; Cronin, S. M. Nephrotoxicity in bone marrow recipients receiving aminoglycoside plus cyclosporine or aminoglycoside alone. J. Antimicrob. Chemother. 1991, 27, 845-849.
13. Elting, L. S.; Rubenstein, E. B.; Kurtin, D.; Rolston, K. V. et al. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer. 1998, 83, 2597-2607.
14. Cantu, T. G.; Yamanaka-Yuen, N. A.; Lietman, P. S. Serum vancomycin concentrations: reappraisal of their clinical value. Clin. Infect. Dis. 1994, 19, 1180-1182.
15. Freeman, C. D.; Quintiliani, R.; Nightingale, C. H. Vancomycin therapeutic drug monitoring: is it necessary? Ann. Pharmacother. 1993, 27, 594-598.
16. Cunha, B. A. Vancomycin. Med. Clin. North. Am. 1995, 79, 817-831.
17. Zeckel, M. L. A closer look at vancomycin teicoplanin, and antimicrobial resistance. J. Chemother. 1997, 9, 311-331.
18. Shea, K. W.; Cuhna, B. A. Teicoplanin. Med. Clin. North. Am. 1995, 79, 833-844.
19. Cimino, M. A.; Rotstein, C.; Slaughter, R. L.; Emrich, L. J. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am. J. Med. 1987, 83, 1091-1097.
20. Zimmermann, A. E.; Katona, B. G.; Plaisance, K. I. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia. Pharmacotherpy. 1995, 15, 85-91.